Zydus Lifesciences informs about press release

06 Jun 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated June 6, 2022 titled ‘Zydus Lifesciences receives final approval from USFDA for Famotidine Tablets’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

886.10 -12.65 (-1.41%)
19-Mar-2026 11:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1766.65
Dr. Reddys Lab 1274.20
Cipla 1251.25
Zydus Lifesciences 886.10
Lupin 2267.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×